Bradley Smith is the Vice President of Translational Medicine at IQVIA, where they lead biomarker and companion diagnostic strategies within the Strategic Drug Development Advisory Group. With over 20 years of experience in biological research across academia and industry, Bradley has a robust background that includes leadership roles at Cell Signaling Technology and Santa Cruz Biotechnology. They completed their Ph.D. in Biology at Stanford University and have held post-doctoral fellowships at UCSF and Stanford. An author of multiple publications and patents, Bradley is dedicated to enhancing drug development and patient care through innovative approaches in precision medicine and genomics.
This person is not in the org chart
This person is not in any teams
This person is not in any offices